Global Drugs for Osteoarthritis Pain Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Drugs for Osteoarthritis Pain will have significant change from previous year. According to our latest study, the global Drugs for Osteoarthritis Pain market size is USD million in 2022 from USD 9037.6 million in 2021, with a change of % between 2021 and 2022. The global Drugs for Osteoarthritis Pain market size will reach USD 13700 million in 2028, growing at a CAGR of 6.1% over the analysis period.
The United States Drugs for Osteoarthritis Pain market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drugs for Osteoarthritis Pain market, reaching US$ million by the year 2028. As for the Europe Drugs for Osteoarthritis Pain landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Drugs for Osteoarthritis Pain players cover Pfizer, Johnson & Johnson, GlaxoSmithKline, and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Osteoarthritis Pain market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Oral
Injection
External
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Medical Care
Personal Care
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs for Osteoarthritis Pain Market Size 2017-2028
2.1.2 Drugs for Osteoarthritis Pain Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Drugs for Osteoarthritis Pain Segment by Type
2.2.1 Oral
2.2.2 Injection
2.2.3 External
2.3 Drugs for Osteoarthritis Pain Market Size by Type
2.3.1 Drugs for Osteoarthritis Pain Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Drugs for Osteoarthritis Pain Market Size Market Share by Type (2017-2022)
2.4 Drugs for Osteoarthritis Pain Segment by Application
2.4.1 Medical Care
2.4.2 Personal Care
2.5 Drugs for Osteoarthritis Pain Market Size by Application
2.5.1 Drugs for Osteoarthritis Pain Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Drugs for Osteoarthritis Pain Market Size Market Share by Application (2017-2022)
3 Drugs for Osteoarthritis Pain Market Size by Player
3.1 Drugs for Osteoarthritis Pain Market Size Market Share by Players
3.1.1 Global Drugs for Osteoarthritis Pain Revenue by Players (2020-2022)
3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2020-2022)
3.2 Global Drugs for Osteoarthritis Pain Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drugs for Osteoarthritis Pain by Regions
4.1 Drugs for Osteoarthritis Pain Market Size by Regions (2017-2022)
4.2 Americas Drugs for Osteoarthritis Pain Market Size Growth (2017-2022)
4.3 APAC Drugs for Osteoarthritis Pain Market Size Growth (2017-2022)
4.4 Europe Drugs for Osteoarthritis Pain Market Size Growth (2017-2022)
4.5 Middle East & Africa Drugs for Osteoarthritis Pain Market Size Growth (2017-2022)
5 Americas
5.1 Americas Drugs for Osteoarthritis Pain Market Size by Country (2017-2022)
5.2 Americas Drugs for Osteoarthritis Pain Market Size by Type (2017-2022)
5.3 Americas Drugs for Osteoarthritis Pain Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs for Osteoarthritis Pain Market Size by Region (2017-2022)
6.2 APAC Drugs for Osteoarthritis Pain Market Size by Type (2017-2022)
6.3 APAC Drugs for Osteoarthritis Pain Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drugs for Osteoarthritis Pain by Country (2017-2022)
7.2 Europe Drugs for Osteoarthritis Pain Market Size by Type (2017-2022)
7.3 Europe Drugs for Osteoarthritis Pain Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drugs for Osteoarthritis Pain by Region (2017-2022)
8.2 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2017-2022)
8.3 Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drugs for Osteoarthritis Pain Market Forecast
10.1 Global Drugs for Osteoarthritis Pain Forecast by Regions (2023-2028)
10.1.1 Global Drugs for Osteoarthritis Pain Forecast by Regions (2023-2028)
10.1.2 Americas Drugs for Osteoarthritis Pain Forecast
10.1.3 APAC Drugs for Osteoarthritis Pain Forecast
10.1.4 Europe Drugs for Osteoarthritis Pain Forecast
10.1.5 Middle East & Africa Drugs for Osteoarthritis Pain Forecast
10.2 Americas Drugs for Osteoarthritis Pain Forecast by Country (2023-2028)
10.2.1 United States Drugs for Osteoarthritis Pain Market Forecast
10.2.2 Canada Drugs for Osteoarthritis Pain Market Forecast
10.2.3 Mexico Drugs for Osteoarthritis Pain Market Forecast
10.2.4 Brazil Drugs for Osteoarthritis Pain Market Forecast
10.3 APAC Drugs for Osteoarthritis Pain Forecast by Region (2023-2028)
10.3.1 China Drugs for Osteoarthritis Pain Market Forecast
10.3.2 Japan Drugs for Osteoarthritis Pain Market Forecast
10.3.3 Korea Drugs for Osteoarthritis Pain Market Forecast
10.3.4 Southeast Asia Drugs for Osteoarthritis Pain Market Forecast
10.3.5 India Drugs for Osteoarthritis Pain Market Forecast
10.3.6 Australia Drugs for Osteoarthritis Pain Market Forecast
10.4 Europe Drugs for Osteoarthritis Pain Forecast by Country (2023-2028)
10.4.1 Germany Drugs for Osteoarthritis Pain Market Forecast
10.4.2 France Drugs for Osteoarthritis Pain Market Forecast
10.4.3 UK Drugs for Osteoarthritis Pain Market Forecast
10.4.4 Italy Drugs for Osteoarthritis Pain Market Forecast
10.4.5 Russia Drugs for Osteoarthritis Pain Market Forecast
10.5 Middle East & Africa Drugs for Osteoarthritis Pain Forecast by Region (2023-2028)
10.5.1 Egypt Drugs for Osteoarthritis Pain Market Forecast
10.5.2 South Africa Drugs for Osteoarthritis Pain Market Forecast
10.5.3 Israel Drugs for Osteoarthritis Pain Market Forecast
10.5.4 Turkey Drugs for Osteoarthritis Pain Market Forecast
10.5.5 GCC Countries Drugs for Osteoarthritis Pain Market Forecast
10.6 Global Drugs for Osteoarthritis Pain Forecast by Type (2023-2028)
10.7 Global Drugs for Osteoarthritis Pain Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Drugs for Osteoarthritis Pain Product Offered
11.1.3 Pfizer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Main Business Overview
11.1.5 Pfizer Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Drugs for Osteoarthritis Pain Product Offered
11.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Drugs for Osteoarthritis Pain Product Offered
11.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 GlaxoSmithKline Main Business Overview
11.3.5 GlaxoSmithKline Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Drugs for Osteoarthritis Pain Product Offered
11.4.3 Bayer Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Drugs for Osteoarthritis Pain Product Offered
11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Eli Lilly Main Business Overview
11.5.5 Eli Lilly Latest Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Drugs for Osteoarthritis Pain Product Offered
11.6.3 Novartis Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Novartis Main Business Overview
11.6.5 Novartis Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Drugs for Osteoarthritis Pain Product Offered
11.7.3 Sanofi Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Information
11.8.2 Horizon Pharma Drugs for Osteoarthritis Pain Product Offered
11.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Horizon Pharma Main Business Overview
11.8.5 Horizon Pharma Latest Developments
11.9 Abbott
11.9.1 Abbott Company Information
11.9.2 Abbott Drugs for Osteoarthritis Pain Product Offered
11.9.3 Abbott Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Abbott Main Business Overview
11.9.5 Abbott Latest Developments
11.10 Mylan
11.10.1 Mylan Company Information
11.10.2 Mylan Drugs for Osteoarthritis Pain Product Offered
11.10.3 Mylan Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Mylan Main Business Overview
11.10.5 Mylan Latest Developments
11. Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Information
11.11.2 Daiichi Sankyo Drugs for Osteoarthritis Pain Product Offered
11.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Daiichi Sankyo Main Business Overview
11.11.5 Daiichi Sankyo Latest Developments
11.12 TEVA
11.12.1 TEVA Company Information
11.12.2 TEVA Drugs for Osteoarthritis Pain Product Offered
11.12.3 TEVA Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 TEVA Main Business Overview
11.12.5 TEVA Latest Developments
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Information
11.13.2 Almatica Pharma Drugs for Osteoarthritis Pain Product Offered
11.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Almatica Pharma Main Business Overview
11.13.5 Almatica Pharma Latest Developments
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Information
11.14.2 Astellas Pharma Drugs for Osteoarthritis Pain Product Offered
11.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Astellas Pharma Main Business Overview
11.14.5 Astellas Pharma Latest Developments
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Information
11.15.2 Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
11.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Tide Pharmaceutical Main Business Overview
11.15.5 Tide Pharmaceutical Latest Developments
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Information
11.16.2 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Offered
11.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Iroko Pharmaceuticals Main Business Overview
11.16.5 Iroko Pharmaceuticals Latest Developments
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Information
11.17.2 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
11.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Hengrui Pharmaceutical Main Business Overview
11.17.5 Hengrui Pharmaceutical Latest Developments
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Information
11.18.2 Abiogen Pharma Drugs for Osteoarthritis Pain Product Offered
11.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Abiogen Pharma Main Business Overview
11.18.5 Abiogen Pharma Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Drugs for Osteoarthritis Pain Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injection
Table 4. Major Players of External
Table 5. Drugs for Osteoarthritis Pain Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Drugs for Osteoarthritis Pain Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Drugs for Osteoarthritis Pain Market Size Market Share by Type (2017-2022)
Table 8. Drugs for Osteoarthritis Pain Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Drugs for Osteoarthritis Pain Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Drugs for Osteoarthritis Pain Market Size Market Share by Application (2017-2022)
Table 11. Global Drugs for Osteoarthritis Pain Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Drugs for Osteoarthritis Pain Revenue Market Share by Player (2020-2022)
Table 13. Drugs for Osteoarthritis Pain Key Players Head office and Products Offered
Table 14. Drugs for Osteoarthritis Pain Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Drugs for Osteoarthritis Pain Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Drugs for Osteoarthritis Pain Market Size Market Share by Regions (2017-2022)
Table 19. Americas Drugs for Osteoarthritis Pain Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Country (2017-2022)
Table 21. Americas Drugs for Osteoarthritis Pain Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Type (2017-2022)
Table 23. Americas Drugs for Osteoarthritis Pain Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Application (2017-2022)
Table 25. APAC Drugs for Osteoarthritis Pain Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Region (2017-2022)
Table 27. APAC Drugs for Osteoarthritis Pain Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Type (2017-2022)
Table 29. APAC Drugs for Osteoarthritis Pain Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Application (2017-2022)
Table 31. Europe Drugs for Osteoarthritis Pain Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Country (2017-2022)
Table 33. Europe Drugs for Osteoarthritis Pain Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Type (2017-2022)
Table 35. Europe Drugs for Osteoarthritis Pain Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Drugs for Osteoarthritis Pain Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Drugs for Osteoarthritis Pain
Table 44. Key Market Challenges & Risks of Drugs for Osteoarthritis Pain
Table 45. Key Industry Trends of Drugs for Osteoarthritis Pain
Table 46. Global Drugs for Osteoarthritis Pain Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Drugs for Osteoarthritis Pain Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Drugs for Osteoarthritis Pain Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Drugs for Osteoarthritis Pain Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Drugs for Osteoarthritis Pain Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Drugs for Osteoarthritis Pain Market Size Market Share Forecast by Application (2023-2028)
Table 52. Pfizer Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 53. Pfizer Drugs for Osteoarthritis Pain Product Offered
Table 54. Pfizer Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Pfizer Main Business
Table 56. Pfizer Latest Developments
Table 57. Johnson & Johnson Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 58. Johnson & Johnson Drugs for Osteoarthritis Pain Product Offered
Table 59. Johnson & Johnson Main Business
Table 60. Johnson & Johnson Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Johnson & Johnson Latest Developments
Table 62. GlaxoSmithKline Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 63. GlaxoSmithKline Drugs for Osteoarthritis Pain Product Offered
Table 64. GlaxoSmithKline Main Business
Table 65. GlaxoSmithKline Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. GlaxoSmithKline Latest Developments
Table 67. Bayer Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 68. Bayer Drugs for Osteoarthritis Pain Product Offered
Table 69. Bayer Main Business
Table 70. Bayer Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Bayer Latest Developments
Table 72. Eli Lilly Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 73. Eli Lilly Drugs for Osteoarthritis Pain Product Offered
Table 74. Eli Lilly Main Business
Table 75. Eli Lilly Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Eli Lilly Latest Developments
Table 77. Novartis Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 78. Novartis Drugs for Osteoarthritis Pain Product Offered
Table 79. Novartis Main Business
Table 80. Novartis Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Novartis Latest Developments
Table 82. Sanofi Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 83. Sanofi Drugs for Osteoarthritis Pain Product Offered
Table 84. Sanofi Main Business
Table 85. Sanofi Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Sanofi Latest Developments
Table 87. Horizon Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 88. Horizon Pharma Drugs for Osteoarthritis Pain Product Offered
Table 89. Horizon Pharma Main Business
Table 90. Horizon Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Horizon Pharma Latest Developments
Table 92. Abbott Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 93. Abbott Drugs for Osteoarthritis Pain Product Offered
Table 94. Abbott Main Business
Table 95. Abbott Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Abbott Latest Developments
Table 97. Mylan Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 98. Mylan Drugs for Osteoarthritis Pain Product Offered
Table 99. Mylan Main Business
Table 100. Mylan Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Mylan Latest Developments
Table 102. Daiichi Sankyo Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 103. Daiichi Sankyo Drugs for Osteoarthritis Pain Product Offered
Table 104. Daiichi Sankyo Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Daiichi Sankyo Main Business
Table 106. Daiichi Sankyo Latest Developments
Table 107. TEVA Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 108. TEVA Drugs for Osteoarthritis Pain Product Offered
Table 109. TEVA Main Business
Table 110. TEVA Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 111. TEVA Latest Developments
Table 112. Almatica Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 113. Almatica Pharma Drugs for Osteoarthritis Pain Product Offered
Table 114. Almatica Pharma Main Business
Table 115. Almatica Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Almatica Pharma Latest Developments
Table 117. Astellas Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 118. Astellas Pharma Drugs for Osteoarthritis Pain Product Offered
Table 119. Astellas Pharma Main Business
Table 120. Astellas Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Astellas Pharma Latest Developments
Table 122. Tide Pharmaceutical Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 123. Tide Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
Table 124. Tide Pharmaceutical Main Business
Table 125. Tide Pharmaceutical Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 126. Tide Pharmaceutical Latest Developments
Table 127. Iroko Pharmaceuticals Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 128. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Product Offered
Table 129. Iroko Pharmaceuticals Main Business
Table 130. Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 131. Iroko Pharmaceuticals Latest Developments
Table 132. Hengrui Pharmaceutical Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 133. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Product Offered
Table 134. Hengrui Pharmaceutical Main Business
Table 135. Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 136. Hengrui Pharmaceutical Latest Developments
Table 137. Abiogen Pharma Details, Company Type, Drugs for Osteoarthritis Pain Area Served and Its Competitors
Table 138. Abiogen Pharma Drugs for Osteoarthritis Pain Product Offered
Table 139. Abiogen Pharma Main Business
Table 140. Abiogen Pharma Drugs for Osteoarthritis Pain Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 141. Abiogen Pharma Latest Developments
List of Figures
Figure 1. Drugs for Osteoarthritis Pain Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs for Osteoarthritis Pain Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Drugs for Osteoarthritis Pain Market Size Market Share by Type in 2021
Figure 7. Drugs for Osteoarthritis Pain in Medical Care
Figure 8. Global Drugs for Osteoarthritis Pain Market: Medical Care (2017-2022) & ($ Millions)
Figure 9. Drugs for Osteoarthritis Pain in Personal Care
Figure 10. Global Drugs for Osteoarthritis Pain Market: Personal Care (2017-2022) & ($ Millions)
Figure 11. Global Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2021
Figure 12. Global Drugs for Osteoarthritis Pain Revenue Market Share by Player in 2021
Figure 13. Global Drugs for Osteoarthritis Pain Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Drugs for Osteoarthritis Pain Market Size 2017-2022 ($ Millions)
Figure 15. APAC Drugs for Osteoarthritis Pain Market Size 2017-2022 ($ Millions)
Figure 16. Europe Drugs for Osteoarthritis Pain Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Drugs for Osteoarthritis Pain Market Size 2017-2022 ($ Millions)
Figure 18. Americas Drugs for Osteoarthritis Pain Value Market Share by Country in 2021
Figure 19. Americas Drugs for Osteoarthritis Pain Consumption Market Share by Type in 2021
Figure 20. Americas Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2021
Figure 21. United States Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Region in 2021
Figure 26. APAC Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2021
Figure 27. China Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Country in 2021
Figure 34. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Type in 2021
Figure 35. Europe Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2021
Figure 36. Germany Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Drugs for Osteoarthritis Pain Market Size Market Share by Application in 2021
Figure 44. Egypt Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Drugs for Osteoarthritis Pain Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 50. APAC Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 51. Europe Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 53. United States Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 54. Canada Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 57. China Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 58. Japan Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 59. Korea Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 61. India Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 62. Australia Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 63. Germany Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 64. France Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 65. UK Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 66. Italy Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 67. Russia Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 68. Spain Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 71. Israel Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Drugs for Osteoarthritis Pain Market Size 2023-2028 ($ Millions)
